Please try another search
Taiwan Biomaterial Co., Ltd. engages in the development and sale of medical devices in Taiwan. The company provides Foamagen, a foamy dura substitute; stroke thrombus negative pressure removal catheter system comprising suction and removal of cerebrovascular embolism blood clot for the pump system, and the nickel-titanium guidewire for guiding cerebral vascular surgery; and tissue repair and regeneration products for the treatment of early osteoarthritis. Taiwan Biomaterial Co., Ltd. Was founded in 2010 and is based in Zhubei, Taiwan.
Name | Age | Since | Title |
---|---|---|---|
Peter Wu | - | 2023 | Independent Director |
Zhimao Lin | - | - | Director |
Min-Jen Chan | - | - | Independent Director |
Shun-Te Lai | - | - | Independent Director |
Ernesto Ko | - | - | Director |
Arthur Lu | - | - | Director |
Hong-Yang Liu | - | - | Director |
Alan Lu | - | 2023 | Chairman of the Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review